LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (16)
2024
-
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Biomedicines, Vol. 12, Núm. 7
-
Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations
Frontiers in Psychology, Vol. 15
2023
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
-
SYNAPSES. Estudio observacional europeo para evaluar la seguridad y la efectividad de la safinamida en la práctica clínica habitual: análisis post hoc de la población española del estudio
Revista de neurologia, Vol. 77, Núm. s02, pp. 1-12
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2022
-
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Frontiers in Neurology, Vol. 13
-
Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation
Frontiers in Pharmacology, Vol. 13
2021
-
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1
Neurologia, Vol. 36, Núm. 2, pp. 149-158
-
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2
Neurologia, Vol. 36, Núm. 2, pp. 159-168
2017
2016
2014
-
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
Neuropharmacology, Vol. 79, pp. 726-737
2013
-
The management of orthostatic hypotension in Parkinson's disease
Frontiers in Neurology, Vol. 4 JUN
2010
-
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)
Movement Disorders, Vol. 25, Núm. 14, pp. 2340-2345